{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T21:15:48Z","timestamp":1781298948914,"version":"3.54.1"},"reference-count":38,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1136\/jnnp-2014-308630","type":"journal-article","created":{"date-parts":[[2014,9,10]],"date-time":"2014-09-10T02:08:55Z","timestamp":1410314935000},"page":"793-798","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":80,"title":["MRI pattern in asymptomatic natalizumab-associated PML"],"prefix":"10.1136","volume":"86","author":[{"given":"Mike P","family":"Wattjes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Vennegoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn D","family":"Steenwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlieke","family":"de Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joep","family":"Killestein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob W","family":"van Oosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jop","family":"Mostert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorine A","family":"Siepman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebe","family":"Moll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex E L","family":"van Golde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan T F M","family":"Frequin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy D","family":"Richert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Barkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2014,9,9]]},"reference":[{"key":"key-10.1136\/jnnp-2014-308630-1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jamaneurol.2013.598","article-title":"Natalizumab: bench to bedside and beyond","volume":"70","author":"Rudick","year":"2013","journal-title":"JAMA Neurol"},{"key":"key-10.1136\/jnnp-2014-308630-2","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized placebo-controlled trial of natalizumab for relapsing remitting multiple sclerosis","volume":"352","author":"Polman","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.1136\/jnnp-2014-308630-3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","article-title":"Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases","volume":"9","author":"Clifford","year":"2010","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2014-308630-4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(10)70040-5","article-title":"Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis","volume":"9","author":"Tan","year":"2010","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2014-308630-5","unstructured":"https:\/\/medinfo.biogenidec.com. March 2014."},{"key":"key-10.1136\/jnnp-2014-308630-6","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","article-title":"PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section","volume":"80","author":"Berger","year":"2013","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-308630-7","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/jnnp-2012-302478","article-title":"Case definition for progressive multifocal leukoencephalopathy following treatment with monoclonal antibodies","volume":"83","author":"Mentzer","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"(Suppl 4)","key":"key-10.1136\/jnnp-2014-308630-8","first-page":"27","article-title":"Imaging findings for PML in natalizumab-treated MS patients","volume":"18","author":"Richert","year":"2012","journal-title":"Mult Scler"},{"key":"key-10.1136\/jnnp-2014-308630-9","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/ana.23676","article-title":"MRI pattern in natalizumab-associated progressive multifocal leukoencephalopathy","volume":"72","author":"Yousry","year":"2012","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-308630-10","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1177\/1352458513510224","article-title":"The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"19","author":"Wattjes","year":"2013","journal-title":"Mult Scler"},{"key":"key-10.1136\/jnnp-2014-308630-11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/WCO.0000000000000099","article-title":"Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI","volume":"27","author":"Wattjes","year":"2014","journal-title":"Curr Opin Neurol"},{"key":"key-10.1136\/jnnp-2014-308630-12","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/jnnp-2011-300511","article-title":"MRI preclinical detection and asymptomatic course of a progressive multifocal leucoencephalopathy (PML) under natalizumab therapy","volume":"83","author":"Phan-Ba","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2014-308630-13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fneur.2013.00011","article-title":"Presymptomatic diagnosis with MRI and adequate treatment ameliorate the outcome after natalizumab-associated progressive multifocal leukoencephalopathy","volume":"4","author":"Lind\u00e5","year":"2013","journal-title":"Front Neurol"},{"key":"key-10.1136\/jnnp-2014-308630-14","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1177\/1352458513481010","article-title":"Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab","volume":"19","author":"Blinkenberg","year":"2013","journal-title":"Mult Scler"},{"key":"key-10.1136\/jnnp-2014-308630-15","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1007\/s00415-012-6426-5","article-title":"Value of MRI as a surrogate marker for PML in natalizumab long-term therapy","volume":"259","author":"Ayzenberg","year":"2012","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2014-308630-16","first-page":"415873","article-title":"Early magnetic resonance detection of natalizumab-related progressive multifocal leukoencephalopathy in a patient with multiple sclerosis","volume":"2013","author":"Manenti","year":"2013","journal-title":"Case Rep Radiol"},{"key":"key-10.1136\/jnnp-2014-308630-17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00415-012-6759-0","article-title":"Asymptomatic progressive multifocal leukoencephalopathy associated with natalizumab","volume":"260","author":"Mc Govern","year":"2013","journal-title":"J Neurol"},{"issue":"(S1)","key":"key-10.1136\/jnnp-2014-308630-18","article-title":"Survival and functional outcome in asymptomatic natalizumab-associated progressive multifocal leukoencephalopathy multiple sclerosis patients","volume":"19","author":"Dong-Si","year":"2013","journal-title":"Mult Scler"},{"key":"key-10.1136\/jnnp-2014-308630-19","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00415-013-7191-9","article-title":"Unusual natalizumab-associated progressive multifocal leukoencephalopathy starting in the brainstem","volume":"261","author":"Havla","year":"2014","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2014-308630-20","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00415-014-7336-5","article-title":"Diagnosis of asymptomatic natalizumab-associated PML: are we between a rock and a hard place?","volume":"261","author":"Wattjes","year":"2014","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2014-308630-21","first-page":"143","article-title":"Fast robust automated brain extraction","volume-title":"Hum Brain Mapp","author":"Smith","year":"2002"},{"key":"key-10.1136\/jnnp-2014-308630-22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1361-8415(01)00036-6","article-title":"A global optimisation method for robust affine registration of brain images","volume":"5","author":"Jenkinson","year":"2001","journal-title":"Med Image Anal"},{"key":"key-10.1136\/jnnp-2014-308630-23","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-308630-24","article-title":"The clinical evaluation of chemotherapeutic agents in cancer","author":"Karnofsky","year":"1949"},{"key":"key-10.1136\/jnnp-2014-308630-25","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa0810316","article-title":"Progressive multifocal leukoencephalopathy after natalizumab monotherapy","volume":"361","author":"Lind\u00e5","year":"2009","journal-title":"N Engl J Med"},{"key":"key-10.1136\/jnnp-2014-308630-26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/jon.12010","article-title":"Presumptive progressive multifocal leukoencephalopathy in multiple sclerosis after natalizumab therapy","volume":"24","author":"Eisele","year":"2014","journal-title":"J Neuroimaging"},{"key":"key-10.1136\/jnnp-2014-308630-27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ana.20933","article-title":"Progressive multifocal leukoencephalopathy revisited: has the disease outgrown its name?","volume":"60","author":"Koralnik","year":"2006","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-308630-28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev-pathol-020712-164018","article-title":"Progressive multifocal leukoencephalopathy: why gray and white matter","volume":"8","author":"Gheuens","year":"2013","journal-title":"Annu Rev Pathol"},{"key":"key-10.1136\/jnnp-2014-308630-29","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/ana.20431","article-title":"JC virus granule cell neuronopathy: a novel clinical syndrome distinct from progressive multifocal leukoencephalopathy","volume":"57","author":"Koralnik","year":"2005","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-308630-30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/NEN.0b013e31823ede59","article-title":"Frequent infection of cortical neurons by JC virus in patients with progressive multifocal leukoencephalopathy","volume":"71","author":"W\u00fcthrich","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"key-10.1136\/jnnp-2014-308630-31","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1212\/01.wnl.0000284601.54436.e4","article-title":"Cortical demyelination in PML and MS: similarities and differences","volume":"70","author":"Moll","year":"2008","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2014-308630-32","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/ana.21619","article-title":"Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons","volume":"65","author":"W\u00fctrich","year":"2009","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-308630-33","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/ana.23973","article-title":"JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment","volume":"74","author":"Schippling","year":"2013","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-308630-34","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1136\/jnnp-2013-304986","article-title":"Punctate lesion pattern suggestive of perivascular inflammation in acute natalizumab-associated progressive multifocal leukoencephalopathy: productive JC virus infection or preclinical PML-IRIS manifestation?","volume":"84","author":"Wattjes","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2014-308630-35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00234-003-1115-9","article-title":"Progressive multifocal leukoencephalopathy: diffusion-weighted imaging and pathological correlations","volume":"46","author":"Bergui","year":"2004","journal-title":"Neuroradiology"},{"key":"key-10.1136\/jnnp-2014-308630-36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/ana.24051","article-title":"Progressive multifocal leukoencephalopathy after natalizumab discontinuation","volume":"75","author":"Fine","year":"2014","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-308630-37","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/ana.24110","article-title":"PML after natalizumab discontinuation: few and true?","volume":"75","author":"Wattjes","year":"2014","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-308630-38","doi-asserted-by":"crossref","DOI":"10.1002\/ana.24153","article-title":"Cerebrospinal Fluid JC Virus Antibody Index for Diagnosis of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy","author":"Warnke","year":"2014","journal-title":"Ann Neurol"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2014-308630","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T17:56:34Z","timestamp":1601056594000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2014-308630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,9]]},"references-count":38,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,6,12]]},"published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.1136\/jnnp-2014-308630"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2014-308630","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,9]]}}}